QA: Seelos Therapeutics INC in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001017491_2019_Seelos_Therapeutics_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001017491, Seelos Therapeutics INC

  xvar xval
0 AssetsCurrent 3,685,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 38,000
3 remainder_Assets 37,000
4 LiabilitiesCurrent 1,172,000
5 LiabilitiesNoncurrent 16,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 8,223,581
9 ResearchAndDevelopmentExpense 1,363,141
10 remainder_Expenses 266
11 remainder_Revenues 0
12 remainder_NetIncome 4,156,345
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 3,760,000
1 Liabilities 1,188,000
2 Expenses 9,586,988
3 Revenues 0
4 StockholdersEquity 2,572,000
5 NetIncome -5,430,643
6 ComprehensiveNetIncome -5,430,643
7 BaseVar 9,345,666
8 EconomicCapitalRatiobeforeLimitedLiability 0.0713
9 EconomicCapitalRatio 1.48

Edgar->Model Mapping

Feature Distribution

Change over Time